VCG
CVS icon

Vantage Consulting Group’s CVS Health CVS Stock Holding History

Vantage Consulting Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,319
Closed -$609K – 46
2024
Q2 		$609K Buy
10,319
+1,879
+22% +$118K 0.45% 18
2024
Q1 		$673K Buy
8,440
+127
+2% +$9.7K 0.43% 17
2023
Q4 		$656K Sell
8,313
-1,656
-17% -$118K 0.44% 17
2023
Q3 		$696K Buy
9,969
+890
+10% +$63.1K 0.47% 14
2023
Q2 		$628K Buy
9,079
+273
+3% +$19.4K 0.36% 14
2023
Q1 		$654K Buy
8,806
+2,066
+31% +$173K 0.37% 14
2022
Q4 		$628K Sell
6,740
-387
-5% -$37.3K 0.37% 14
2022
Q3 		$680K Sell
7,127
-184
-3% -$18.2K 0.4% 13
2022
Q2 		$677K Buy
7,311
+1,027
+16% +$100K 0.38% 12
2022
Q1 		$636K Sell
6,284
-1,166
-16% -$122K 0.25% 14
2021
Q4 		$769K Sell
7,450
-794
-10% -$73.4K 0.21% 15
2021
Q3 		$700K Buy
8,244
+283
+4% +$23.7K 0.15% 15
2021
Q2 		$664K Buy
7,961
+1,461
+22% +$120K 0.12% 17
2021
Q1 		$489K Buy
6,500
+1,985
+44% +$145K 0.1% 16
2020
Q4 		$308K Buy
+4,515
New +$294K 0.03% 16

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Vantage Consulting Group's CVS Position: Q3 2024 in Review

Vantage Consulting Group sold out of CVS Health (CVS) in Q3 2024, closing a stake of 10,319 shares — an estimated $609K sold.

Vantage Consulting Group first reported a position in CVS in Q4 2020 and held it in 15 quarters. The position peaked at $769K in Q4 2021. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Vantage Consulting Group reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • Vantage Consulting Group sold 10,319 CVS Health shares in Q3 2024, an estimated $609K.
  • Vantage Consulting Group first reported a position in CVS Health in Q4 2020 and held it in 15 quarters.
  • Vantage Consulting Group's CVS Health position peaked at $769K in Q4 2021.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Vantage Consulting Group's 13F filing for Q3 2024, filed 14 Nov 2024.